AstraZeneca will supply 200 doses of the coronavirus vaccine candidate AZD1222 to the U.S. Army under a $286.9M firm-fixed-price contract.
AstraZeneca and the Department of Health and Human Services have signed a potential $1.2B public-private partnership agreement to further develop a recombinant adenovirus vaccine…
